PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 90.70
+1.40 (1.57%)
At close: Jun 29, 2026
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 9.28 million as of June 30, 2026. Its market cap has increased by 30.63% in one year.
Market Cap
9.28M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
90.70
Market Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 9.28M, a decrease of -97.18%. That is a compound annual growth rate of -51.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 9.20M | -5.96% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
| Jul 25, 2021 | 329.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.00B |
| Kamada | 1.23B |
| InterCure | 173.18M |
| Rekah Pharmaceutical Industry | 121.68M |
| Seach Medical Group | 79.83M |
| Together Pharma | 40.99M |
| Nextage Therapeutics | 14.73M |
| Tikun Olam-Cannbit Pharmaceuticals | 9.92M |